Summit Therapeutics (SMMT) Return on Assets (2020 - 2025)

Summit Therapeutics' Return on Assets history runs 6 years deep, the most recent figure standing at 0.0% for Q3 2025.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.0% (changed 0.0% YoY) and the FY2024 annual result came in at 0.06%, down 5.0% from the prior year.
• Return on Assets was 0.0% for Q3 2025 at Summit Therapeutics, up from 0.0% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q4 2022 and bottomed at 0.03% in Q4 2023.
• A 5-year average of 0.01% and a median of 0.01% in 2022 frame the typical range for Return on Assets.
• Annual changes were most pronounced in 2023 — Return on Assets slipped 3 bps — and 2024, when it grew 2 bps.
• Summit Therapeutics' Return on Assets stood at 0.01% in 2021, then soared by 75 bps to 0.0% in 2022, then plunged by 1552 bps to 0.03% in 2023, then soared by 83 bps to 0.01% in 2024, then jumped by 52 bps to 0.0% in 2025.
• Business Quant data shows SMMT's Return on Assets at 0.0% in Q3 2025, 0.0% in Q2 2025, and 0.0% in Q1 2025.